Accelerate to discover
Related topics
April 2024 publication revealing benefits of using intravital microscopy in trascriptomics studies
May 8, 2024
Transcriptional activation of Bmal1 drives the inflammatory activity of monocytes by modulating mitochondrial unfolded...
Minimal information for studies of extracellular vesicles (MISEV2023)
May 7, 2024
MISEV2023 is intended to aid any and all EV researchers: from those just starting their EV journey to more established...
Omics Studies of Tumor Cells under Microgravity Conditions
May 6, 2024
It is important for the analysis of data from space experiments to distinguish unspecific stress reactions from...
Column-Free CD14+ Monocyte Isolation using 50nm Superparamagentic Beads on MARS® Bar
Apr 25, 2024
The MARS® Bar Magnetic Separation Platform is a closed and automated isolation for cell therapy development and...
Spatial and temporal profiling of the complement system uncovered novel functions of the alternative
Apr 24, 2024
Mounting evidence implicated the classical complement pathway (CP) in normal brain development, and the pathogenesis of...
The chicken chorioallantoic membrane as a low-cost, high-throughput model for cancer imaging
Apr 4, 2024
Here, we assessed the chicken chorioallantoic membrane (CAM) as an alternative to mice for preclinical cancer imaging...
A microthrombus-driven fixed-point cleaved nanosystem for preventing post-thrombolysis recurrence
Apr 3, 2024
A thrombin-responsive and fixed-point cleaved Fu@pep-CLipo was developed for highly efficient and precise thrombolysis...
Webinar: Multimodal Assessment of Hypoxia in Tumors: From the Lab to the Clinic
Apr 2, 2024
25 April 2024, 4PM CET
This webinar will be of interest to multiple profiles in the community of biomedical...
Feb 20, 2020
In this study is demonstrated that microPET-based dosimetry of an unconventional radionuclide such as 152Tb is feasible, and the comparison with organ harvesting resulted in acceptable dose discrepancies for body parts that could be segmented on CT. These encouraging results warrant additional validation using radiolabeled molecules with a different biodistribution pattern.
Related technologies: PET, SPECT, CT
Get more info
Brand profile
Bruker is a performace leader in preclinical imaging instrumentation. Bruker offers nine imaging modalities: PET, SPECT, CT, MRI, MPI, fluorescence, luminiscence, radioisotipic imaging and X-ray.
More info at:
www.bruker.com
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
